PPT1 and hepatocellular carcinoma: Coincidently, our data here suggested a mechanism that AEG-1 stability is negatively controlled by its site-specific palmitoylation, and increasing AEG-1 palmitoylation via inhibiting PPT1 by HCQ restrains HCC progression.